FeesSafety
Pluang+

Canton Strategic Holdings' Nasdaq stock to trade as tokens on Canton Network starting Nov 2 under SEC rules.

Market News
02 Nov 2026, 23:19 WIB
CryptoTicker
View Source
Neutral
Canton Strategic Holdings' Nasdaq stock to trade as tokens on Canton Network starting Nov 2 under SEC rules.

Starting November 2, Canton Strategic Holdings' common shares will be tradable as tokens on the Canton Network via TSV LLC, under a new SEC innovation exemption valid until 2031. This tokenized trading is limited by strict volume caps and requires participant approval, making it a small, controlled market rather than a broad public exchange. For German investors, the traditional Nasdaq stock remains the accessible option, while tokenized shares carry full shareholder rights but are subject to flat-rate withholding tax and regulatory restrictions. The launch marks a significant step in tokenized securities but with modest trading volume and regulatory oversight.

Canton Coin tokenized stock data is context for readers. For those following major cryptocurrencies on Pluang as of Nov 03, 2026 03:31 WIB: out of 50 assets, 5 rose and 44 fell. Notable movers include CAKE at Rp33.349 with a -3.82% change and 92% sell order activity, YFI at Rp34.890.432 with -3.81% change and 63% buy order activity, and THETA at Rp2.733 with -3.73% change and 100% buy order activity.

More News

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
1 hour ago
Exosens reports 50.9M shares and 59.1M voting rights as of October 31, 2026

Exosens reports 50.9M shares and 59.1M voting rights as of October 31, 2026

Exosens disclosed its monthly update on the total number of shares and voting rights in its share capital as of October 31, 2026. The company has 50,936,749 shares outstanding, with 59,162,039 exercisable voting rights after deducting treasury shares...

Company Fundamentals
Neutral
4 hours ago
Exosens reports total shares and voting rights as of October 31, 2026, confirming capital structure details.

Exosens reports total shares and voting rights as of October 31, 2026, confirming capital structure details.

Exosens has released its monthly update on the total number of shares and voting rights composing its capital as of October 31, 2026. The company reports 50,936,749 total shares and 59,425,768 theoretical voting rights, with 59,162,039 exercisable vo...

Company Fundamentals
Neutral
4 hours ago
Phase 2 trial shows REC-4881 cuts polyp burden in FAP patients with durable effects and good safety.

Phase 2 trial shows REC-4881 cuts polyp burden in FAP patients with durable effects and good safety.

Recursion Pharmaceuticals announced positive Phase 2 results for REC-4881, an oral MEK1/2 inhibitor, in treating familial adenomatous polyposis (FAP). The TUPELO trial showed a 47% median reduction in total polyp burden after 12 weeks of treatment, w...

Company Fundamentals
Bullish
5 hours ago
Vornado reports Q3 2026 net loss of $47M but FFO rises to $0.65 per share, announces major 350 Park Ave joint venture.

Vornado reports Q3 2026 net loss of $47M but FFO rises to $0.65 per share, announces major 350 Park Ave joint venture.

Vornado Realty Trust reported a net loss of $47.1 million for Q3 2026, a decline from net income of $11.6 million in the prior year period, primarily due to a large gain in 2025 related to a master lease. However, funds from operations (FFO) increase...

Company Fundamentals
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App